U.S., June 19 -- ClinicalTrials.gov registry received information related to the study (NCT07026734) titled 'The Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson Disease' on June 10.
Brief Summary: Nearly one-million people in North America are now living with Parkinson's disease (PD), and that number is projected to rise to nearly 1.2 million by 2030. With advancements in neuromodulatory technologies, increasingly more of these individuals elect to undergo deep brain stimulation (DBS) surgery in order to control symptoms of the disease, including refractory tremor, medication-induced dyskinesias, and PD-associated dystonia. The two most common DBS neural targets for controlling these symptoms are the globus pal...